UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012032 |
|---|---|
| Receipt number | R000014062 |
| Scientific Title | Phase Ib study of 131I-metaiodobenzylguanidine(MIBG) therapy with Valproic Acid(VPA) for high risk or recurrent neuroblastoma |
| Date of disclosure of the study information | 2013/10/14 |
| Last modified on | 2020/02/04 14:34:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/10/14 20:31:51 | ||
| 2 | Update | 2013/10/14 20:37:25 | Date of disclosure of the study information |
|
| 3 | Update | 2019/02/26 17:00:30 | UMIN ID1 |
|
| 4 | Update | 2020/02/04 14:31:34 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Category of Funding Organization Organization Organization Address Address Tel |
|
| 5 | Update | 2020/02/04 14:34:00 | Recruitment status Date of IRB Last follow-up date |
